{
    "title": "Pfizer's Comirnaty, Paxlovid push Q2 sales to new heights",
    "url": "https://www.dailymail.co.uk/wires/ap/article-11058275/Pfizers-Comirnaty-Paxlovid-push-Q2-sales-new-heights.html",
    "date": "2022-07-28",
    "keywords": [
        "pfizer",
        "vaccine",
        "comirnaty",
        "share",
        "treatment",
        "revenue",
        "quarter",
        "paxlovid",
        "giant",
        "history",
        "thursday",
        "york",
        "forecast",
        "disease",
        "covid19",
        "cash",
        "stockpile",
        "cancer",
        "coronavirus",
        "company",
        "investment",
        "research",
        "inc",
        "end",
        "factset",
        "logo",
        "companys",
        "headquarters",
        "ap",
        "photomark",
        "lennihan",
        "file",
        "outlook",
        "use",
        "control",
        "prevention",
        "product",
        "booster",
        "majority",
        "profit",
        "cost",
        "development",
        "partner",
        "biontech",
        "portion",
        "migraine",
        "developer",
        "health",
        "heart",
        "obesity",
        "kidney",
        "liver",
        "course",
        "day",
        "president",
        "joe",
        "biden",
        "bout",
        "aside",
        "medicine",
        "eliquis",
        "blood",
        "morning",
        "trading"
    ],
    "category": [
        "wires",
        "ap"
    ]
}